Associated Banc-Corp (ASB) does not present a compelling buy opportunity for a beginner investor with a long-term horizon at this time. While the technical indicators show some bullish trends, the financial performance is concerning with significant YoY declines in net income and EPS. Analysts have upgraded the stock recently, but the price target increases are modest, and there are no strong catalysts to suggest immediate upside potential. The lack of significant insider or hedge fund activity, as well as no recent congress trading data, further supports a cautious approach.
The technical indicators show a bullish trend with MACD above 0 and positively contracting, RSI in a neutral zone at 64.757, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 27.775), which could limit short-term upside.

Recent analyst upgrades to 'Overweight' with higher price targets, citing strong growth trajectory and potential benefits from higher interest rates. Appointment of a new market president to strengthen regional presence.
Lack of significant insider or hedge fund activity. No recent congress trading data.
In Q4 2025, revenue increased significantly by 533.42% YoY, but net income dropped by -181.63%, and EPS fell by -176.92%. Gross margin remains at 0%. The financials indicate growth in revenue but poor profitability metrics.
Recent upgrades from Barclays and Stephens to 'Overweight' with price targets of $33 and $29, respectively. Truist lowered its price target to $27, citing higher cost of equity. Analysts are generally optimistic but with mixed views on valuation.